
The University of Kansas Cancer Center is transforming cancer research and clinical care by linking our innovative approach to drug discovery, delivery and development to our nationally accredited patient care program. Our partnership includes cancer research and healthcare professionals associated with the University of Kansas Medical Center and The University of Kansas Hospital in Kansas City, The University of Kansas in Lawrence, the University of Kansas School of Medicine in Wichita, and the members of the Midwest Cancer Alliance.
- Nanotax: The University of Kansas Cancer Center is currently enrolling patients in this Phase I Clinical Trial.
Click here to learn more.
- Institute for Advancing Medical Innovation
Led by Scott Weir, PharmD, PhD, the Institute focuses on the discovery and commercialization of medical innovations, and training the next generation of translational scientists. For more information on the Institute, visit the web site at http://www2.kumc.edu/iami/
Purchase Your Driven to Cure License Plate Today